Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in poststroke depression

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstrazct

Depression is the most common psychiatric complication after stroke. Its prevalence varies from 20% to 80%, and it is underdiagnosed and undertreated. It has significant impact on rehabilitation, motor recovery, activities of daily living, social and interpersonal life, and mortality. Several studies have shown that biological and psychosocial factors play significant roles in the development of this disabling disease. Recent research shows that neurochemical processes also may play some role in the pathophysiology of this condition. Several trials have shown evidence that the older, as well as newer antidepressants and psychostimulants may reduce/prevent depressive symptoms after stroke. At this point there are no clear guidelines available to choose safe and effective treatments. Drugs are selected based on their efficacy and side effect profile in these patients. More research is needed to understand the pathophysiology of depression after stroke. There also is a need for more randomized clinical trials to better treat patients with this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Whyte EM, Mulsant BH: Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002, 52:253–264.

    Article  PubMed  Google Scholar 

  2. Ghose SS, Williams LS, Swindle RW: Depression and other mental health diagnoses after stroke increase inpatient and outpatient medical utilization three years poststroke. Med Care 2005, 43:1259–1264.

    Article  PubMed  Google Scholar 

  3. Jia H, Damush TM, Qin H, et al.: The impact of poststroke depression on healthcare use by veterans with acute stroke. Stroke 2006, 37:2796–2801.

    Article  PubMed  Google Scholar 

  4. Robinson RG: Vascular depression and poststroke depression: where do we go from here? Am J Geriatr Psychiatry 2005, 13:85–87.

    Article  PubMed  Google Scholar 

  5. Bhogal SK, Teasell R, Foley N, Speechley M: Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc 2005, 53:1051–1057.

    Article  PubMed  Google Scholar 

  6. Williams LS, Ghose SS, Swindle RW: Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004, 161:1090–1095.

    Article  PubMed  Google Scholar 

  7. Carota A, Berney A, Aybek S, et al.: A prospective study of predictors of poststroke depression. Neurology 2005, 64:428–433.

    PubMed  CAS  Google Scholar 

  8. Dieguez S, Staub F, Bruggimann L, Bogousslavsky J: Is poststroke depression a vascular depression? J Neurol Sci 2004, 226:53–58.

    Article  PubMed  Google Scholar 

  9. Pohjasvaara T, Leppavuori A, Siira I, et al.: Frequency and clinical determinants of poststroke depression. Stroke 1998, 29:2311–2317.

    PubMed  CAS  Google Scholar 

  10. Spalletta G, Ripa A, Caltagirone C: Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients. Am J Geriatr Psychiatry 2005, 13:108–115.

    Article  PubMed  Google Scholar 

  11. Paul SL, Dewey HM, Sturm JW, et al.: Prevalence of depression and use of antidepressant medication at 5-years poststroke in the North East Melbourne Stroke Incidence Study. Stroke 2006, 37:2854–2855.

    Article  PubMed  CAS  Google Scholar 

  12. Ouimet MA, Primeau F, Cole MG: Psychosocial risk factors in poststroke depression: a systematic review. Can J Psychiatry 2001, 46:819–828.

    PubMed  CAS  Google Scholar 

  13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1995.

    Google Scholar 

  14. Robinson RG, Starr LB, Lipsey JR, et al.: A two-year longitudinal study of post-stroke mood disorders: dynamic changes in associated variables over the first six months of follow-up. Stroke 1984, 15:510–517.

    PubMed  CAS  Google Scholar 

  15. Bhogal SK, Teasell R, Foley N, et al.: Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc 2005, 53:1051–1057.

    Article  PubMed  Google Scholar 

  16. Bozikas VP, Gold G, Kovari E, et al.: Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry 2005, 13:166–169.

    Article  PubMed  Google Scholar 

  17. Carson AJ, MacHale S, Allen K, et al.: Depression after stroke and lesion location: a systematic review. Lancet 2000, 356:122–126.

    Article  PubMed  CAS  Google Scholar 

  18. Narushima K, Kosier JT, Robinson RG: A reappraisal of poststroke depression, intra-and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003, 15:422–430.

    PubMed  CAS  Google Scholar 

  19. Vataja R, Pohjasvaara T, Mantyla R, et al.: Depression-executive dysfunction syndrome in stroke patients. Am J Geriatr Psychiatry 2005, 13:99–107.

    Article  PubMed  Google Scholar 

  20. Kales HC, Maixner DF, Mellow AM: Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry 2005, 13:88–98.

    Article  PubMed  Google Scholar 

  21. Craft TK, DeVries AC: Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 2006, 60:812–818.

    Article  PubMed  CAS  Google Scholar 

  22. Spalletta G, Bossu P, Ciaramella A, et al.: The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006, 11:984–991.

    Article  PubMed  CAS  Google Scholar 

  23. Ramasubbu R, Tobias R, Buchan AM, et al.: Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J Neuropsychiatry Clin Neurosci 2006, 18:96–99.

    PubMed  CAS  Google Scholar 

  24. Lipsey JR, Robinson RG, Pearlson GD, et al.: Nortriptyline treatment of poststroke depression: a double-blind study. Lancet 1984, 1:297–300.

    Article  PubMed  CAS  Google Scholar 

  25. Robinson RG, Schultz SK, Castillo C, et al.: Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000, 157:351–359.

    Article  PubMed  CAS  Google Scholar 

  26. Narushima K, Kosier JT, Robinson R, et al.: Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002, 190:296–303.

    Article  PubMed  Google Scholar 

  27. Jorge RE, Robinson RG, Arndt S, et al.: Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003, 160:1823–1829.

    Article  PubMed  Google Scholar 

  28. Lauritzen L, Bendsen BB, Vilmar T, et al.: Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology 1994, 114:119–122.

    Article  PubMed  CAS  Google Scholar 

  29. Wiart L, Petit H, Joseph PA, et al.: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000, 31:1829–1832.

    PubMed  CAS  Google Scholar 

  30. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U: Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003, 250:347–351.

    Article  PubMed  CAS  Google Scholar 

  31. Dam M, Tonin P, De Boni A, et al.: Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996, 27:1211–1214.

    PubMed  CAS  Google Scholar 

  32. Murray V, von Arbin M, Bartfai A, et al.: Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005, 66:708–716.

    PubMed  CAS  Google Scholar 

  33. Rasmussen A, Lunde M, Poulsen DL, et al.: A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003, 44:216–221.

    Article  PubMed  CAS  Google Scholar 

  34. Almeida OP, Waterreus A, Hankey GJ: Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 2006, 67:1104–1109.

    Article  PubMed  Google Scholar 

  35. Andersen G, Vestergaard K, Lauritzen L, et al.: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099–1104.

    PubMed  CAS  Google Scholar 

  36. Rampello L, Chiechio S, Nicoletti G, et al.: Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology (Berl) 2004, 173:73–78.

    Article  CAS  Google Scholar 

  37. Dahmen N, Marx J, Hopf HC, et al.: Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke 1999, 30:691–692.

    PubMed  CAS  Google Scholar 

  38. Kimura M, Kanetani K, Imai R, et al.: Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. Int Clin Psychopharmacol 2002, 17:121–125.

    Article  PubMed  CAS  Google Scholar 

  39. Niedermaier N, Bohrer E, Schulte K, et al.: Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 2004, 65:1619–1623.

    Article  PubMed  CAS  Google Scholar 

  40. Grade C, Redford B, Chrostowski J, et al.: Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998, 79:1047–1050.

    Article  PubMed  CAS  Google Scholar 

  41. Reding MJ, Orto LA, Winter SW, et al.: Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986, 43:763–765.

    PubMed  CAS  Google Scholar 

  42. Roh JK, Lee KH, Kim M, Yamamoto M: Accelerated recovery from ischemic stroke with indeloxazine hydrochloride: results of a double-masked clinical study in Korea. Curr Ther Res Clin Exp 1996, 57:632–642.

    Article  CAS  Google Scholar 

  43. Raffaele R, Rampello L, Vecchio I, et al.: Trazodone therapy of the post-stroke depression. Arch Gerontol Geriatr 1996, 23(Suppl 5):217–220.

    Article  Google Scholar 

  44. Palomaki H, Kaste M, Berg A, et al.: Prevention of poststroke depression: 1 year randomized placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999, 66:490–494.

    Article  PubMed  CAS  Google Scholar 

  45. Rampello L, Alvano A, Chiechio S, et al.: An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr 2005, 40:275–285.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke Psychiatry Specialty Clinic, 2000 Regency Parkway, Suite 280, Cary, NC, 27518, USA

    Haresh M. Tharwani MD

Authors
  1. Haresh M. Tharwani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pavan Yerramsetty MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Mannelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ashwin Patkar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prakash Masand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haresh M. Tharwani MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tharwani, H.M., Yerramsetty, P., Mannelli, P. et al. Recent advances in poststroke depression. Curr Psychiatry Rep 9, 225–231 (2007). https://doi.org/10.1007/s11920-007-0023-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0023-9

Keywords

Search

Navigation